Winslow Capital Management
VRTX icon

Winslow Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Winslow Capital Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-887,640
Closed -$405M – 70
2025
Q4 		$405M Buy
+887,640
New +$383M 1.36% 24
2025
Q2 		– Sell
-419
Closed -$203K – 73
2025
Q1 		$203K Buy
+419
New +$195K ﹤0.01% 63
2024
Q4 		– Sell
-516
Closed -$240K – 70
2024
Q3 		$240K Sell
516
-6
-1% -$2.88K ﹤0.01% 61
2024
Q2 		$245K Sell
522
-92
-15% -$39.9K ﹤0.01% 55
2024
Q1 		$257K Sell
614
-924,755
-100% -$391M ﹤0.01% 55
2023
Q4 		$377M Sell
925,369
-194,223
-17% -$71.7M 1.56% 21
2023
Q3 		$389M Sell
1,119,592
-19,349
-2% -$6.77M 1.85% 19
2023
Q2 		$401M Buy
1,138,941
+650,966
+133% +$219M 1.8% 17
2023
Q1 		$154M Buy
+487,975
New +$146M 0.78% 43
2016
Q1 		– Sell
-2,501,991
Closed -$315M – 156
2015
Q4 		$315M Sell
2,501,991
-419,795
-14% -$50.7M 1.13% 42
2015
Q3 		$304M Sell
2,921,786
-105,356
-3% -$13.5M 1.11% 42
2015
Q2 		$374M Sell
3,027,142
-648,273
-18% -$81.7M 1.24% 29
2015
Q1 		$434M Buy
3,675,415
+1,850,944
+101% +$222M 1.34% 32
2014
Q4 		$217M Buy
+1,824,471
New +$205M 0.67% 59

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Winslow Capital Management's VRTX Position: Q1 2026 in Review

Winslow Capital Management sold out of Vertex Pharmaceuticals (VRTX) in Q1 2026, closing a stake of 887,640 shares — an estimated $405M sold.

Winslow Capital Management first reported a position in VRTX in Q4 2014 and held it in 14 quarters. The position peaked at $434M in Q1 2015. 1,697 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Winslow Capital Management reported no remaining Vertex Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Winslow Capital Management sold 887,640 Vertex Pharmaceuticals shares in Q1 2026, an estimated $405M.
  • Winslow Capital Management first reported a position in Vertex Pharmaceuticals in Q4 2014 and held it in 14 quarters.
  • Winslow Capital Management's Vertex Pharmaceuticals position peaked at $434M in Q1 2015.
  • 1,697 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Winslow Capital Management's 13F filing for Q1 2026, filed 14 May 2026.